ICD-10-CM Code C50.122

Valid for Submission

C50.122 is a billable code used to specify a medical diagnosis of malignant neoplasm of central portion of left male breast. The code is valid for the year 2020 for the submission of HIPAA-covered transactions.

The code C50.122 is applicable to male patients only. It is clinically and virtually impossible to use this code on a non-male patient.

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

• Diagnoses for males only - Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, this code applies to MALES only .

Diagnostic Related Groups

The ICD-10 code C50.122 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2019 through 09/30/2020.

• 582 - MASTECTOMY FOR MALIGNANCY WITH CC/MCC
• 583 - MASTECTOMY FOR MALIGNANCY WITHOUT CC/MCC

Convert C50.122 to ICD-9

• 175.9 - Mal neo male breast NEC (Approximate Flag)

Code Classification

• Neoplasms (C00–D48)
  • Malignant neoplasms of breast (C50)
    • Malignant neoplasm of breast (C50)

Code History

• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
  (First year ICD-10-CM implemented into the HIPAA code set)
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Tools

• Copy Code
• Copy Description
• View Related Codes
• Convert C50.122 to ICD-9